COVID-19 Quarantine Dramatically Affected Male Sexual Behavior: Is There a Possibility to Go Back to Normality?
COVID-19
erectile function
sexual satisfaction
sexual well-being
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
08 May 2022
08 May 2022
Historique:
received:
15
03
2022
revised:
27
04
2022
accepted:
03
05
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
15
5
2022
Statut:
epublish
Résumé
We performed a monocentric longitudinal study on sexually active male patients, from May 2021 to October 2021, with SARS-CoV-2 infection confirmed with a nasopharyngeal reverse transcriptase polymerase chain reaction (RT-PCR). The questionnaires were delivered by email. The study period was divided into the periods before getting tested (T1), during quarantine (T2), 1 month after a negative test (T3), and 3 months after a negative test (T4). All participants were invited to complete these questionnaires: 10- and 6-item questionnaires, a sexual distress schedule (SDS), and the international index of erectile function questionnaire of 15 items (IIEF-15). The primary endpoint was to evaluate the impact of quarantine on male sexual function (SF) during and after the SARS-CoV-2 infection. A total of 22 male patients met the inclusion criteria. The differences for both SDS and IIEF-15 scores, between T1−T2 (27 (IQR 24.0−32.2) vs. 37.5 (IQR 34.2−45.5), 45 (IQR 38.0−50.2) vs. 28.5 (IQR 19.5−38.0)), T2−T3 (37.5 (IQR 34.2−45.5) vs. 28 (IQR 24.0−31.0), and 28.5 (IQR 19.5−38.0) vs. 39.5 (IQR 35.5−44.2)) were statistically significant (p < 0.001), respectively. Moreover, between T1−T4, no statistically significant difference (p > 0.05) was recorded in both SDS (27 (IQR 24.0−32.2) vs. 26.5 (IQR 24−30.2)) and IIEF-15 (45 (IQR 38.0−50.2) vs. 28.5 (IQR 19.5−38.0)). In 20 patients (90.9%), SARS-CoV-2 had a huge impact on relationship and sexual life, but no patient attended a clinic for sexual difficulties. In conclusion quarantine has negatively influenced SF in infected patients; however, 3 months after the rRT-PCR negative test, a promising return to the preinfection SF values is observed.
Identifiants
pubmed: 35566771
pii: jcm11092645
doi: 10.3390/jcm11092645
pmc: PMC9100217
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Sex Med. 2020 Jul;17(7):1225-1228
pubmed: 32418751
Reprod Toxicol. 2021 Jan;99:65-70
pubmed: 33249233
Adv Virol. 2020 Dec 09;2020:8826943
pubmed: 33376490
Minerva Endocrinol. 2020 Jun;45(2):77-78
pubmed: 32270992
JAMA. 2020 May 12;323(18):1846-1848
pubmed: 32215581
Lancet. 2020 Nov 7;396(10261):1525-1534
pubmed: 32979936
J Sex Med. 2020 Jul;17(7):1222-1224
pubmed: 32487463
Sex Med Rev. 2017 Jul;5(3):349-364
pubmed: 28596070
Fertil Steril. 2020 Jun;113(6):1154
pubmed: 32387274
Urology. 1997 Jun;49(6):822-30
pubmed: 9187685
Int J Gynaecol Obstet. 2020 Jul;150(1):98-102
pubmed: 32392400
J Androl. 2007 Mar-Apr;28(2):223-8
pubmed: 17021333
Arch Sex Behav. 2018 Aug;47(6):1733-1743
pubmed: 29557994
New Sci. 2021 Dec 4;252(3363):7
pubmed: 34876769
JAMA Netw Open. 2020 May 1;3(5):e208292
pubmed: 32379329
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143